142 related articles for article (PubMed ID: 26295711)
21. Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection.
Lai MS; Hsieh MS; Chiu YH; Chen TH
Hepatology; 2006 Jun; 43(6):1295-302. PubMed ID: 16729295
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
[TBL] [Abstract][Full Text] [Related]
23. Analysis of factors affecting the appearance of hepatocellular carcinoma in patients with chronic hepatitis C. A long term follow-up study after histologic diagnosis.
Aizawa Y; Shibamoto Y; Takagi I; Zeniya M; Toda G
Cancer; 2000 Jul; 89(1):53-9. PubMed ID: 10897000
[TBL] [Abstract][Full Text] [Related]
24. Is female sex a significant favorable prognostic factor in hepatocellular carcinoma?
Farinati F; Sergio A; Giacomin A; Di Nolfo MA; Del Poggio P; Benvegnù L; Rapaccini G; Zoli M; Borzio F; Giannini EG; Caturelli E; Trevisani F;
Eur J Gastroenterol Hepatol; 2009 Oct; 21(10):1212-8. PubMed ID: 19465859
[TBL] [Abstract][Full Text] [Related]
25. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan.
Chen CL; Yang HI; Yang WS; Liu CJ; Chen PJ; You SL; Wang LY; Sun CA; Lu SN; Chen DS; Chen CJ
Gastroenterology; 2008 Jul; 135(1):111-21. PubMed ID: 18505690
[TBL] [Abstract][Full Text] [Related]
26. Characteristics and prognosis of patients in Japan with viral marker-negative hepatocellular carcinoma.
Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J
J Gastroenterol Hepatol; 2008 Mar; 23(3):459-66. PubMed ID: 17854425
[TBL] [Abstract][Full Text] [Related]
27. The Differential Immunohistochemical Expression of p53, c-Jun, c-Myc, and p21 Between HCV-related Hepatocellular Carcinoma With and Without Cirrhosis.
Abdou AG; Abd-Elwahed M; Badr M; Helmy M; Soliman EA; Maher D
Appl Immunohistochem Mol Morphol; 2016 Feb; 24(2):75-87. PubMed ID: 25710583
[TBL] [Abstract][Full Text] [Related]
28. Risk of depressive disorder following non-alcoholic cirrhosis: a nationwide population-based study.
Perng CL; Shen CC; Hu LY; Yeh CM; Chen MH; Tsai CF; Chiang HL; Hung YP; Su VY; Hu YW; Su TP; Chen PM; Hung JH; Liu CJ; Huang MW
PLoS One; 2014; 9(2):e88721. PubMed ID: 24533141
[TBL] [Abstract][Full Text] [Related]
29. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
30. Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001.
Giordano TP; Kramer JR; Souchek J; Richardson P; El-Serag HB
Arch Intern Med; 2004 Nov; 164(21):2349-54. PubMed ID: 15557414
[TBL] [Abstract][Full Text] [Related]
31. Pediatric sleep apnea and depressive disorders risk: A population-based 15-year retrospective cohort study.
Chang CH; Chen SJ; Liu CY
PLoS One; 2017; 12(7):e0181430. PubMed ID: 28708880
[TBL] [Abstract][Full Text] [Related]
32. Pretreatment platelet count early predicts extrahepatic metastasis of human hepatoma.
Lee CH; Lin YJ; Lin CC; Yen CL; Shen CH; Chang CJ; Hsieh SY
Liver Int; 2015 Oct; 35(10):2327-36. PubMed ID: 25752212
[TBL] [Abstract][Full Text] [Related]
33. Combination of racial/ethnic and etiology/disease-specific factors is associated with lower survival following liver transplantation in African Americans: an analysis from UNOS/OPTN database.
Wong RJ; Ahmed A
Clin Transplant; 2014 Jul; 28(7):755-61. PubMed ID: 24750171
[TBL] [Abstract][Full Text] [Related]
34. Impact of viral hepatitis on outcomes after liver resection for hepatocellular carcinoma: results from a north american center.
Lee JJ; Kim PT; Fischer S; Fung S; Gallinger S; McGilvray I; Moulton CA; Wei AC; Greig PD; Cleary SP
Ann Surg Oncol; 2014 Aug; 21(8):2708-16. PubMed ID: 24806113
[TBL] [Abstract][Full Text] [Related]
35. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M
Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
[TBL] [Abstract][Full Text] [Related]
36. Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma.
Lu SN; Wang JH; Liu SL; Hung CH; Chen CH; Tung HD; Chen TM; Huang WS; Lee CM; Chen CC; Changchien CS
Cancer; 2006 Nov; 107(9):2212-22. PubMed ID: 17019738
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of AFP and ultrasound tests on hepatocellular carcinoma mortality in HCV-infected patients in the USA.
El-Serag HB; Kramer JR; Chen GJ; Duan Z; Richardson PA; Davila JA
Gut; 2011 Jul; 60(7):992-7. PubMed ID: 21257990
[TBL] [Abstract][Full Text] [Related]
38. Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a population-based cohort study, 1992-2007.
Thein HH; Walter SR; Gidding HF; Amin J; Law MG; George J; Dore GJ
J Viral Hepat; 2011 Jul; 18(7):e232-41. PubMed ID: 21692938
[TBL] [Abstract][Full Text] [Related]
39. Effect of interferon-alpha on progression of cirrhosis to hepatocellular carcinoma: a retrospective cohort study. International Interferon-alpha Hepatocellular Carcinoma Study Group.
Lancet; 1998 May; 351(9115):1535-9. PubMed ID: 10326535
[TBL] [Abstract][Full Text] [Related]
40. Second primary cancers in patients with hepatocellular carcinoma: a nationwide cohort study in Taiwan.
Wu WC; Chen YT; Hwang CY; Su CW; Li SY; Chen TJ; Liu CJ; Kao WY; Chao Y; Lin HC; Wu JC
Liver Int; 2013 Apr; 33(4):616-23. PubMed ID: 23331767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
